Public Launch of SISAQOL-IMI
Recommendations

Event description:

The Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints – Innovative Medicines Initiative (SISAQOL-IMI) consortium will hold its public launch on February 4, 2025, during the concluding Consensus Meeting. This event is open to external stakeholders and will feature key highlights from the recommendations, examples of stakeholder implementations, and a panel discussion on how various stakeholders can contribute to implementing the SISAQOL-IMI recommendations in cancer clinical trials.

Registration:

For online participation please register HERE until January 31st, 2025.

If you would like to attend in person, please contact directly sisaqolimi@eortc.org by January 6, 2025. The number of spaces in our event are limited and seats are being allocated on a first-come, first-serve basis.  Address of the venue: Hotel Marriot Ghent (Korenlei 10, 9000 Gent), Belgium.

For all additional information, please contact Monika Turek monika.turek@eortc.org.